Wolverine Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-88,906	Closed	-$236K	–	1779
2025 Q3	$236K	Hold	88,906	–	–	﹤0.01%	991
2025 Q2	$87.5K	Hold	88,906	–	–	﹤0.01%	1143
2025 Q1	$128K	Buy	88,906 +1,522	+2%	+$2.81K	﹤0.01%	1070
2024 Q4	$192K	Hold	87,384	–	–	﹤0.01%	1031
2024 Q3	$144K	Hold	87,384	–	–	﹤0.01%	1065
2024 Q2	$194K	Hold	87,384	–	–	﹤0.01%	1002
2024 Q1	$234K	Hold	87,384	–	–	﹤0.01%	938
2023 Q4	$261K	Hold	87,384	–	–	﹤0.01%	1008
2023 Q3	$85.6K	Hold	87,384	–	–	﹤0.01%	1165
2023 Q2	$121K	Hold	87,384	–	–	﹤0.01%	1054
2023 Q1	$139K	Hold	87,384	–	–	﹤0.01%	1071
2022 Q4	$544K	Sell	87,384 -57,861	-40%	-$414K	0.01%	927
2022 Q3	$973K	Sell	145,245 -2,624	-2%	-$18K	0.01%	797
2022 Q2	$940K	Sell	147,869 -1,732	-1%	-$9.82K	0.01%	805
2022 Q1	$694K	Buy	149,601 +5,969	+4%	+$25.6K	0.01%	882
2021 Q4	$718K	Buy	143,632 +28,432	+25%	+$228K	0.01%	911
2021 Q3	$1.39M	Buy	115,200 +40,200	+54%	+$585K	0.02%	614
2021 Q2	$1.59M	Buy	+75,000	New	+$1.81M	0.01%	497
2021 Q1	–	Hold	0	–	–	–	2120